← Medical · Causes of death · how systems treat it
Cancer · Master rank #19 · ~1.7% of deaths (Top 20 avg)
Short comparison of all 20 systems on one page. Click a country for the full treatment / prevention / lifestyle page.
High visit frequency, low unit prices, specialist access without US-style referral walls. East Asia leans harder on H. pylori and endoscopy. National stomach-cancer awareness and endoscopy culture
Very high utilization; hospital-heavy; aggressive screening culture. East Asia leans harder on H. pylori and endoscopy. National cancer screening includes stomach endoscopy tracks
High ambulatory volume; global budgets constrain growth. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via NHI single payer.
Public clusters for most serious care; private ISP for those who pay up. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via S+3Ms (subsidy + MediSave + MediShield + MediFund).
Strong primary care; Mediterranean public-health framing. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via SNS tax-funded.
GP gatekeeping; north/south performance gaps. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via SSN tax-funded.
Insurer-organized pathways; low uninsured rate. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Mandatory private insurance, regulated.
GP gatekeeping, NICE pathways, waiting-list rationing for elective care. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via NHS tax-funded.
Primary-care centered; strong public health infrastructure. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Decentralized tax-funded.
Wealthy Nordic model; GP lists + municipal prevention. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Tax-funded national system.
Ambulatory specialist access; strong pharma/device availability. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Statutory health insurance.
High spend, high access, canton variation. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Mandatory private insurance.
Municipal prevention + regional hospitals. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Tax-funded.
Single-payer core with wait times; limited private parallel. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Single payer (provincial).
Ambulatory specialists + hospital sector; dense capacity. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Statutory sickness funds.
Fund-integrated care; strong tech/trauma capacity. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Mandatory health funds.
Public primary care + occupational health overlay. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Tax-funded / reforming.
Strong primary care gatekeeping with private hospital overflow. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Universal Medicare + private optional.
Pharmac constrains drug spend; public hospitals for major care. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Tax-funded + private optional.
High-tech acute care; prior auth; huge price variation by payer. East Asia leans harder on H. pylori and endoscopy. Cancer pathway via Medicare/Medicaid + commercial.